Phenotypic vs. genotypic resistance to fluoroquinolones in rifampicin-resistant TB

Int J Tuberc Lung Dis. 2021 Oct 1;25(10):861-863. doi: 10.5588/ijtld.21.0184.

Authors

S Tahseen¹, F M Khanzada¹, A Hussain¹, N Akhtar²

Affiliations

¹ National TB Reference Laboratory, National TB Control Programme, Islamabad, Pakistan.
² National Tuberculosis Control Programme, Islamabad, Pakistan, Pakistan Institute of Medical sciences, Islamabad, Pakistan.

PMID: 34615584
DOI: 10.5588/ijtld.21.0184

No abstract available

MeSH terms

Antitubercular Agents / pharmacology
Antitubercular Agents / therapeutic use
Fluoroquinolones / pharmacology
Genotype
Humans
Microbial Sensitivity Tests
Mycobacterium tuberculosis* / genetics
Rifampin / pharmacology
Tuberculosis, Multidrug-Resistant* / drug therapy

Substances

Antitubercular Agents
Fluoroquinolones
Rifampin